HK1072251A1 - Piperidine derivative - Google Patents

Piperidine derivative

Info

Publication number: HK1072251A1
Authority: HK; Hong Kong
Prior art keywords: piperidine derivative; piperidine; derivative
Prior art date: 2002-02-08

Application number

HK05103492A

Other languages

English (en)

Inventor

Giuseppe Alvaro

Romano Di Fabio

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-02-08

Filing date

2005-04-22

Publication date

2005-08-19

2005-04-22 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2005-08-19 Publication of HK1072251A1 publication Critical patent/HK1072251A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Immunology (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Addiction (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)

HK05103492A 2002-02-08 2005-04-22 Piperidine derivative HK1072251A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0203020.3A GB0203020D0 (en)	2002-02-08	2002-02-08	Chemical compounds
PCT/EP2003/001308 WO2003066635A1 (en)	2002-02-08	2003-02-10	Piperidine derivatives

Publications (1)

Publication Number	Publication Date
HK1072251A1 true HK1072251A1 (en)	2005-08-19

Family

ID=9930717

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK05103492A HK1072251A1 (en)	2002-02-08	2005-04-22	Piperidine derivative

Country Status (27)

Country	Link
US (3)	US7189713B2 (xx)
EP (2)	EP1666465B1 (xx)
JP (1)	JP4488743B2 (xx)
KR (1)	KR101011316B1 (xx)
CN (1)	CN1319973C (xx)
AR (1)	AR038818A1 (xx)
AT (2)	ATE394375T1 (xx)
AU (1)	AU2003205753B9 (xx)
BR (1)	BRPI0307123B8 (xx)
CA (1)	CA2475619C (xx)
CO (1)	CO5611152A2 (xx)
DE (2)	DE60302137T2 (xx)
DK (1)	DK1472256T3 (xx)
ES (2)	ES2304660T3 (xx)
GB (1)	GB0203020D0 (xx)
HK (1)	HK1072251A1 (xx)
IL (2)	IL162765A0 (xx)
IS (1)	IS2402B (xx)
MX (1)	MXPA04006791A (xx)
MY (1)	MY130411A (xx)
NO (1)	NO329379B1 (xx)
NZ (1)	NZ533785A (xx)
PL (1)	PL211082B1 (xx)
RU (1)	RU2336276C2 (xx)
TW (1)	TWI291466B (xx)
WO (1)	WO2003066635A1 (xx)
ZA (1)	ZA200404842B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0203020D0 (en) *	2002-02-08	2002-03-27	Glaxo Group Ltd	Chemical compounds
TWI283241B (en)	2002-05-29	2007-07-01	Tanabe Seiyaku Co	Novel piperidine compound
WO2004067093A2 (en) *	2003-01-27	2004-08-12	Glaxo Group Limited	Nk1 receptor antagonists for the treatment of functional dyspepsia
GB0308968D0 (en) *	2003-04-17	2003-05-28	Glaxo Group Ltd	Medicaments
US20060030600A1 (en) *	2004-08-06	2006-02-09	Patrick Schnider	Dual NK1/NK3 receptor antagonists for the treatment of schizophrenia
AU2006221984C1 (en) *	2005-03-08	2012-02-09	Janssen Pharmaceutica N.V.	Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists
JO2722B1 (en) *	2005-09-09	2013-09-15	سميث كلاين بيتشام كوربوريشن	New vehicles
AR057828A1 (es)	2005-09-29	2007-12-19	Astrazeneca Ab	Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
CA2636946A1 (en) *	2006-01-11	2007-07-19	Merck And Co., Inc.	Fused triazole tachykinin receptor antagonists
US7872022B2 (en) *	2006-04-03	2011-01-18	Hoffmann-La Roche Inc.	Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety
GB0621229D0 (en) *	2006-10-20	2006-12-06	Glaxo Group Ltd	Novel use
JP2010516731A (ja)	2007-01-24	2010-05-20	グラクソグループリミテッド	２−メトキシ−５−（５−トリフルオロメチル−テトラゾール−１−イル）−ベンジル］−（２ｓ−フェニル−ピペリジン−３ｓ−イル）−アミンを含む医薬組成物
EP2170064A4 (en) *	2007-06-22	2010-08-04	Merck Sharp & Dohme	6,5-pyrrolopiperidine tachykinin receptor antagonists
GB0806652D0 (en) *	2008-04-11	2008-05-14	Glaxo Group Ltd	Anhydrous crystal form of orvepitant maleate
GB0812849D0 (en) *	2008-07-14	2008-08-20	Glaxo Wellcome Mfg Pte Ltd	Novel compounds
GB0814340D0 (en)	2008-08-05	2008-09-10	Smithkline Beecham Corp	Anhydrous crystol form fo a pyridine derivative
ES2672099T3 (es)	2011-07-04	2018-06-12	Irbm - Science Park S.P.A.	Antagonistas del receptor NK-1 para el tratamiento de la neovascularización corneal
AU2013224181A1 (en) *	2012-02-22	2014-10-02	Leo Pharma A/S	Novel neurokinin 1 receptor antagonist compounds
WO2014057003A1 (en) *	2012-10-11	2014-04-17	Nerre Therapeutics Limited	Novel uses
WO2015024203A1 (en) *	2013-08-20	2015-02-26	Leo Pharma A/S	Novel neurokinin 1 receptor antagonist compounds ii
CN105579456A (zh) *	2013-08-20	2016-05-11	利奥制药有限公司	新型神经激肽1受体拮抗剂化合物ii
SI3377064T1 (sl) *	2016-01-08	2019-11-29	Nerre Therapeutics Ltd	Orvepitant za zdravljenje kroničnega kašlja
IL312486B1 (en)	2017-04-10	2025-01-01	Chase Therapeutics Corp	NK1 antagonist combination and method for treating synucleinopathies
MA49524A (fr)	2017-06-30	2021-05-26	Chase Therapeutics Corp	Compositions d'antagoniste de nk-1 et méthodes destinées à être utilisées dans le traitement de la dépression
JP2023519570A (ja)	2020-04-03	2023-05-11	ネッレセラピューティクスリミテッド	新規使用
CA3177477A1 (en)	2020-06-02	2021-12-09	Nerre Therapeutics Limited	Neurokinin (nk)-1 receptor antagonists for use in the treatment of pulmonary fibrosis conditions promoted by mechanical injury to the lungs

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4219554A (en)	1974-05-09	1980-08-26	Toyama Chemical Company, Limited	Novel penicillins and cephalosporins and process for producing same
US4379152A (en)	1974-05-09	1983-04-05	Toyama Chemical Co., Ltd.	Cephalosporins
US4110327A (en)	1974-05-09	1978-08-29	Toyama Chemical Co., Ltd.	2,3 Diketo-piperazinocarbonylamino alkanoic acids and derivatives
US4410522A (en)	1974-05-09	1983-10-18	Toyama Chemical Co., Ltd.	Cephalosporins
US4087424A (en)	1974-05-09	1978-05-02	Toyama Chemical Co., Ltd.	Novel penicillins and cephalosporins and process for producing the same
US4327097A (en)	1974-05-09	1982-04-27	Toyama Chemical Co., Ltd.	Novel penicillins
US4112090A (en)	1974-05-09	1978-09-05	Toyama Chemical Co., Ltd.	Novel penicillins and cephalosporins and process for producing the same
IL47168A (en)	1974-05-09	1979-07-25	Toyama Chemical Co Ltd	Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
NO154582C (no)	1978-10-20	1986-11-05	Ferrosan Ab	Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider.
JPS57118587A (en)	1981-11-26	1982-07-23	Toyama Chem Co Ltd	Novel penicillin
KR910009880B1 (ko)	1983-07-25	1991-12-03	가부시기가이샤 히다찌세이사꾸쇼	인터레이스된 텔레비젼 신호중의 화상의 움직임 검출회로
US5028610A (en)	1987-03-18	1991-07-02	Sankyo Company Limited	N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use
GB8709666D0 (en)	1987-04-23	1987-05-28	Beecham Group Plc	Compounds
GB8713061D0 (en)	1987-06-04	1987-07-08	Beecham Group Plc	Compounds
US5109014A (en)	1990-12-10	1992-04-28	Jacobson Richard M	N-aryl-3-aryl-4-substituted-2,3,4,5-tetrahydro-1H-pyrazole-1-carboxamides
SE9100860D0 (sv)	1991-03-22	1991-03-22	Kabi Pharmacia Ab	New use
GB9106127D0 (en)	1991-03-22	1991-05-08	Byrne Charles M	Spread
MY110227A (en)	1991-08-12	1998-03-31	Ciba Geigy Ag	1-acylpiperindine compounds.
EP0533280B2 (en)	1991-09-20	2004-12-01	Glaxo Group Limited	Novel medical use for tachykinin antagonists
CA2083891A1 (en)	1991-12-03	1993-06-04	Angus Murray Macleod	Heterocyclic compounds, compositions containing them and their use in therapy
US5563127A (en)	1993-03-24	1996-10-08	The Dupont Merck Pharmaceutical Company	Boronic acid and ester inhibitors of thrombin
US5348955A (en)	1993-06-22	1994-09-20	Merck & Co., Inc.	N,N-diacylpiperazines
IL111730A (en)	1993-11-29	1998-12-06	Fujisawa Pharmaceutical Co	Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL112778A0 (en)	1994-03-04	1995-05-26	Merck & Co Inc	Substituted heterocycles, their preparation and pharmaceutical compositions containing them
US5464788A (en)	1994-03-24	1995-11-07	Merck & Co., Inc.	Tocolytic oxytocin receptor antagonists
DE4425146A1 (de)	1994-07-15	1996-01-18	Basf Ag	Verwendung heterocyclischer Verbindungen
NZ289498A (en)	1994-07-15	1998-02-26	Meiji Seika Co	Piperidinylpiperazine derivatives such as various piperidinylpiperazinylacetylphenoxy acetic acid derivatives, pharmaceutical compositions
AU3085895A (en)	1994-07-26	1996-02-22	Sankyo Company Limited	N-phenylated amide and urea derivatives
DE19520499C2 (de)	1994-09-17	2003-06-18	Boehringer Ingelheim Kg	Neurokinin-Antagonisten, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende pharmazeutische Zusammensetzungen sowie ihre Verwendung
US5696123A (en)	1994-09-17	1997-12-09	Boehringer Ingelheim Kg	Neurokinin antagonists
DE69525355T2 (de)	1994-09-30	2002-09-19	Novartis Ag, Basel	1-acyl-4-aliphatische aminopiperidin verbindungen
DE69534213T2 (de)	1994-10-25	2006-01-12	Astrazeneca Ab	Therapeutisch wirksame Heterocyclen
US5998444A (en)	1995-10-24	1999-12-07	Zeneca Ltd.	Piperidinyl compounds as NK1 or NK2 antagonists
US5629322A (en)	1994-11-15	1997-05-13	Merck & Co., Inc.	Cyclic amidine analogs as inhibitors of nitric oxide synthase
US5576317A (en)	1994-12-09	1996-11-19	Pfizer Inc.	NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
AU4432496A (en)	1994-12-23	1996-07-19	Dr. Karl Thomae Gmbh	Piperazine derivatives, medicaments containing the same, their use and process for preparing the same
US5700801A (en)	1994-12-23	1997-12-23	Karl Thomae, Gmbh	Piperazine derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
IL117149A0 (en)	1995-02-23	1996-06-18	Schering Corp	Muscarinic antagonists
NZ321575A (en)	1995-10-30	1999-05-28	Janssen Pharmaceutica Nv	1-(1,2-disubstituted piperidinyl)-4- substituted piperazine derivatives
WO1997016400A1 (en) *	1995-10-31	1997-05-09	Unichema Chemie B.V.	Process for the deparaffination of squalane
TW531537B (en)	1995-12-27	2003-05-11	Janssen Pharmaceutica Nv	1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives
DE19608665A1 (de)	1996-03-06	1997-09-11	Boehringer Ingelheim Kg	Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US6057323A (en)	1996-03-08	2000-05-02	Adolor Corporation	Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
CA2249604A1 (en)	1996-04-03	1997-10-09	Theresa M. Williams	Inhibitors of farnesyl-protein transferase
US5859012A (en)	1996-04-03	1999-01-12	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
WO1997036592A1 (en)	1996-04-03	1997-10-09	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
CA2249599A1 (en)	1996-04-03	1997-10-09	Dong D. Wei	Inhibitors of farnesyl-protein transferase
WO1998001133A1 (fr)	1996-07-08	1998-01-15	Yamanouchi Pharmaceutical Co., Ltd.	Inhibiteurs de la resorption osseuse
US6117855A (en)	1996-10-07	2000-09-12	Merck Sharp & Dohme Ltd.	Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent
US5929077A (en)	1996-11-08	1999-07-27	Leftheris; Katerina	Thioproline-containing inhibitors of farnesyl protein transferase
US6114315A (en)	1996-12-02	2000-09-05	Merck Sharp & Dohme Ltd.	Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety
US5977104A (en)	1996-12-02	1999-11-02	Merck Sharp & Dohme Ltd.	Use of NK-1 receptor antagonists for treating bipolar disorders
AU731672B2 (en)	1996-12-02	2001-04-05	Merck Sharp & Dohme Limited	Use of NK-1 receptor antagonists for treating bipolar disorders
DE19652273A1 (de) *	1996-12-16	1998-06-18	Basf Ag	Monoolefinische C¶5¶-Mononitrile, Verfahren zu ihrer Herstellung und ihre Verwendung
AUPO735997A0 (en)	1997-06-17	1997-07-10	Fujisawa Pharmaceutical Co., Ltd.	Piperazine derivatives
EP1014984A1 (en)	1997-08-27	2000-07-05	Merck & Co., Inc.	Inhibitors of prenyl-protein transferase
WO1999026921A1 (en)	1997-11-24	1999-06-03	Merck & Co., Inc.	SUBSTITUTED β-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS
KR20010034442A (ko)	1998-01-27	2001-04-25	아벤티스 파마슈티칼즈 프로덕츠 인코포레이티드	치환된 옥소아자헤테로사이클릴 인자 Ｘａ 억제제
GB9923748D0 (en)	1999-10-07	1999-12-08	Glaxo Group Ltd	Chemical compounds
JP2004501903A (ja)	2000-06-29	2004-01-22	藤沢薬品工業株式会社	ベンズヒドリル誘導体
AUPR237301A0 (en)	2001-01-02	2001-01-25	Fujisawa Pharmaceutical Co., Ltd.	Benzhydryl derivatives
DE50110956D1 (de)	2000-10-12	2006-10-19	Viromics Gmbh	Proteasome inhibitoren zur behandlung von hepatitis-virus infektionen
GB0025354D0 (en) *	2000-10-17	2000-11-29	Glaxo Group Ltd	Chemical compounds
US20030022891A1 (en)	2000-12-01	2003-01-30	Anandan Palani	MCH antagonists and their use in the treatment of obesity
GB0203020D0 (en) *	2002-02-08	2002-03-27	Glaxo Group Ltd	Chemical compounds
US20040029865A1 (en)	2002-05-23	2004-02-12	Acker Brad A.	Bis-arylsulfones
MY141736A (en)	2002-10-08	2010-06-15	Elanco Animal Health Ireland	Substituted 1,4-di-piperidin-4-yi-piperazine derivatives and their use as neurokinin antagonists
GB0308968D0 (en) *	2003-04-17	2003-05-28	Glaxo Group Ltd	Medicaments

2002
- 2002-02-08 GB GBGB0203020.3A patent/GB0203020D0/en not_active Ceased
2003
- 2003-02-06 AR ARP030100377A patent/AR038818A1/es active IP Right Grant
- 2003-02-06 MY MYPI20030409A patent/MY130411A/en unknown
- 2003-02-06 TW TW092102350A patent/TWI291466B/zh not_active IP Right Cessation
- 2003-02-10 IL IL16276503A patent/IL162765A0/xx unknown
- 2003-02-10 AT AT05077500T patent/ATE394375T1/de not_active IP Right Cessation
- 2003-02-10 KR KR1020047012190A patent/KR101011316B1/ko active IP Right Grant
- 2003-02-10 ES ES05077500T patent/ES2304660T3/es not_active Expired - Lifetime
- 2003-02-10 AT AT03702621T patent/ATE308543T1/de active
- 2003-02-10 NZ NZ533785A patent/NZ533785A/en not_active IP Right Cessation
- 2003-02-10 CA CA2475619A patent/CA2475619C/en not_active Expired - Lifetime
- 2003-02-10 RU RU2004126957/04A patent/RU2336276C2/ru active
- 2003-02-10 EP EP05077500A patent/EP1666465B1/en not_active Expired - Lifetime
- 2003-02-10 JP JP2003566008A patent/JP4488743B2/ja not_active Expired - Lifetime
- 2003-02-10 US US10/502,255 patent/US7189713B2/en not_active Expired - Lifetime
- 2003-02-10 WO PCT/EP2003/001308 patent/WO2003066635A1/en active IP Right Grant
- 2003-02-10 BR BRPI0307123A patent/BRPI0307123B8/pt not_active IP Right Cessation
- 2003-02-10 ES ES03702621T patent/ES2250870T3/es not_active Expired - Lifetime
- 2003-02-10 AU AU2003205753A patent/AU2003205753B9/en not_active Expired
- 2003-02-10 CN CNB03803431XA patent/CN1319973C/zh not_active Expired - Lifetime
- 2003-02-10 DE DE60302137T patent/DE60302137T2/de not_active Expired - Lifetime
- 2003-02-10 DE DE60320865T patent/DE60320865D1/de not_active Expired - Lifetime
- 2003-02-10 EP EP03702621A patent/EP1472256B1/en not_active Expired - Lifetime
- 2003-02-10 DK DK03702621T patent/DK1472256T3/da active
- 2003-02-10 PL PL373532A patent/PL211082B1/pl unknown
- 2003-02-10 MX MXPA04006791A patent/MXPA04006791A/es active IP Right Grant
2004
- 2004-06-18 ZA ZA2004/04842A patent/ZA200404842B/en unknown
- 2004-06-28 IL IL162765A patent/IL162765A/en active IP Right Grant
- 2004-08-02 NO NO20043239A patent/NO329379B1/no not_active IP Right Cessation
- 2004-08-04 IS IS7382A patent/IS2402B/is unknown
- 2004-08-06 CO CO04076757A patent/CO5611152A2/es active IP Right Grant
2005
- 2005-04-22 HK HK05103492A patent/HK1072251A1/xx not_active IP Right Cessation
2006
- 2006-12-11 US US11/608,853 patent/US7652012B2/en not_active Expired - Lifetime
2009
- 2009-12-08 US US12/633,265 patent/US20100152446A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1666465B1 (en)	2008-05-07
TWI291466B (en)	2007-12-21
RU2004126957A (ru)	2005-04-20
ATE308543T1 (de)	2005-11-15
GB0203020D0 (en)	2002-03-27
ZA200404842B (en)	2005-09-28
US20100152446A1 (en)	2010-06-17
BRPI0307123B1 (pt)	2018-06-19
DE60302137D1 (de)	2005-12-08
US7189713B2 (en)	2007-03-13
MY130411A (en)	2007-06-29
NO20043239L (no)	2004-08-02
PL211082B1 (pl)	2012-04-30
PL373532A1 (en)	2005-09-05
TW200400192A (en)	2004-01-01
NZ533785A (en)	2007-05-31
KR101011316B1 (ko)	2011-01-28
US20070099914A1 (en)	2007-05-03
ES2250870T3 (es)	2006-04-16
BRPI0307123B8 (pt)	2021-05-25
CN1628115A (zh)	2005-06-15
RU2336276C2 (ru)	2008-10-20
IS7382A (is)	2004-08-04
IS2402B (is)	2008-09-15
DE60302137T2 (de)	2006-07-20
NO329379B1 (no)	2010-10-04
AU2003205753B8 (en)	2010-02-18
BR0307123A (pt)	2004-12-07
KR20040086354A (ko)	2004-10-08
CA2475619A1 (en)	2003-08-14
CO5611152A2 (es)	2006-02-28
US20050176715A1 (en)	2005-08-11
AU2003205753B9 (en)	2010-03-04
ATE394375T1 (de)	2008-05-15
MXPA04006791A (es)	2004-12-06
AR038818A1 (es)	2005-01-26
CN1319973C (zh)	2007-06-06
AU2003205753B2 (en)	2010-01-07
ES2304660T3 (es)	2008-10-16
US7652012B2 (en)	2010-01-26
JP2005524637A (ja)	2005-08-18
EP1666465A1 (en)	2006-06-07
IL162765A (en)	2012-04-30
IL162765A0 (en)	2005-11-20
EP1472256B1 (en)	2005-11-02
WO2003066635A1 (en)	2003-08-14
NO20043239D0 (no)	2004-08-02
AU2003205753A1 (en)	2003-09-02
CA2475619C (en)	2011-04-12
DK1472256T3 (da)	2006-03-20
JP4488743B2 (ja)	2010-06-23
EP1472256A1 (en)	2004-11-03
DE60320865D1 (de)	2008-06-19

Publication	Publication Date	Title
EP1549646A4 (en)	2008-05-21	DERIVATIVES OF PIPERIDINE
HUS1400037I1 (hu)	2017-08-28	Új 2-piridiletilbenzamid származékok
HK1072251A1 (en)	2005-08-19	Piperidine derivative
GB0219896D0 (en)	2002-10-02	Dihydropyridine derivatives
AP1850A (en)	2008-05-26	Spiroindolineplperidine derivatives
EG24050A (en)	2008-04-13	Heterocylocarboxamide derivatives
HK1091204A1 (en)	2007-01-12	Heteroarylcarbamoylbenzene derivative
HK1077068A1 (en)	2006-02-03	Azolidinone-vinyl fused-benzene derivatives
IL166121A0 (en)	2006-01-15	Indole-3-sulphur derivatives
EP1522540A4 (en)	2011-08-10	AZAARENE DERIVATIVES
IL176562A0 (en)	2006-10-31	Amidopyrazole derivative
PL376475A1 (en)	2005-12-27	N-substituted-2-oxodihydropyridine derivatives
ZA200500294B (en)	2006-08-30	Novel 2-pyridylethylbenzamide derivative
IL166426A0 (en)	2006-01-15	N-biarylmethyl aminocycloalkanecarboxamide derivatives
HK1079201A1 (en)	2006-03-31	Isoindoline derivative
AU2003231388A1 (en)	2003-11-10	Novel piperidine derivative
HK1077066A1 (en)	2006-02-03	Novel piperidine compound
EG25699A (en)	2012-05-22	N-aryl piperidine substituted biphenylcarboxamides
AU2003264753A1 (en)	2004-04-30	1-sulphonyl piperidine derivatives
AU2003222659A8 (en)	2003-11-03	23-o-substituted 5-o-mycaminosyltylonide derivatives
EP1531854A4 (en)	2006-06-28	O-DERIVATED NOCATHIACIN DERIVATIVES
GB0213488D0 (en)	2002-07-24	2-Naphthamide derivatives
AU2003243397A8 (en)	2003-12-19	Homo-camptothecin derivatives
AU2003235095A1 (en)	2003-12-12	Piperidine derivatives
SI1472256T1 (sl)	2006-04-30	Piperidinovi derivati

Legal Events

Date	Code	Title	Description
2014-09-05	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20140210